GB1388178A - Benzylpyrimidine derivatives - Google Patents

Benzylpyrimidine derivatives

Info

Publication number
GB1388178A
GB1388178A GB5529072A GB5529072A GB1388178A GB 1388178 A GB1388178 A GB 1388178A GB 5529072 A GB5529072 A GB 5529072A GB 5529072 A GB5529072 A GB 5529072A GB 1388178 A GB1388178 A GB 1388178A
Authority
GB
United Kingdom
Prior art keywords
antibiotic
salt
sulphonamide
benzylpyrimidine derivatives
benzylpyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5529072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1388178A publication Critical patent/GB1388178A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GB5529072A 1971-12-01 1972-11-30 Benzylpyrimidine derivatives Expired GB1388178A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20386971A 1971-12-01 1971-12-01
US404953A US3867527A (en) 1971-12-01 1973-10-10 2,4-Diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine
US00404954A US3850962A (en) 1971-12-01 1973-10-10 2,4-diamino-5-(3-alkoxy-4,5-methylene-dioxybenzyl)pyrimidine
US05/531,135 US3962435A (en) 1971-12-01 1974-12-09 Combination of oxytetracycline and 2,4-diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine

Publications (1)

Publication Number Publication Date
GB1388178A true GB1388178A (en) 1975-03-26

Family

ID=27498515

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5529072A Expired GB1388178A (en) 1971-12-01 1972-11-30 Benzylpyrimidine derivatives
GB2289274A Expired GB1388180A (en) 1971-12-01 1972-11-30 Acetals

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2289274A Expired GB1388180A (en) 1971-12-01 1972-11-30 Acetals

Country Status (12)

Country Link
US (3) US3850962A (cg-RX-API-DMAC7.html)
JP (1) JPS5523830B2 (cg-RX-API-DMAC7.html)
AT (1) AT321310B (cg-RX-API-DMAC7.html)
AU (1) AU467566B2 (cg-RX-API-DMAC7.html)
BE (1) BE792096A (cg-RX-API-DMAC7.html)
CA (1) CA994345A (cg-RX-API-DMAC7.html)
CH (1) CH569009A5 (cg-RX-API-DMAC7.html)
DE (1) DE2252807A1 (cg-RX-API-DMAC7.html)
FR (1) FR2162177B1 (cg-RX-API-DMAC7.html)
GB (2) GB1388178A (cg-RX-API-DMAC7.html)
NL (1) NL176563C (cg-RX-API-DMAC7.html)
SE (3) SE397349B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
US3978086A (en) * 1973-04-13 1976-08-31 Sandoz, Inc. 2-Amino-4,5-methylenedioxyphenyl nitriles
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4075209A (en) * 1977-02-07 1978-02-21 Hoffmann-La Roche, Inc. Process for preparing substituted 2,4-diaminopyrimidines and isoxazole intermediate
AT384023B (de) * 1980-11-11 1987-09-25 Wellcome Found Verfahren zur herstellung von neuen 2,4-diamino-5-(subst.)pyrimidinen und deren salzen, n-oxiden und n-acylderivaten
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
EP3741842A4 (en) 2018-09-27 2021-04-21 TERUMO Kabushiki Kaisha CELL CRYOPRESERVATION METHOD

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628236A (en) * 1953-02-10 S-benzyl
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
NL122146C (cg-RX-API-DMAC7.html) * 1960-09-02
FR1453056A (fr) * 1964-11-12 1966-04-15 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE1620729A1 (de) * 1965-07-08 1970-08-20 Wellcome Found Verfahren zur Herstellung von substituierten Benzylpyrimidinen
DK120706B (da) * 1969-01-27 1971-07-05 Egyt Gyogyszervegyeszeti Gyar Fremgangsmåde til fremstilling af 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin.
CH513181A (de) * 1969-06-12 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung von N-Oxyden von Benzylpyrimidinen
US3787409A (en) * 1970-09-14 1974-01-22 Hoffmann La Roche 2,4-diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine
GB1375162A (cg-RX-API-DMAC7.html) * 1970-10-22 1974-11-27
RO67383A (ro) * 1970-10-22 1981-07-30 The Wellcome Foundation Ltd,Gb Procedeu pentru prepararea unor 2,4-diamino-5-benzilpirimidine
DE2165363A1 (de) * 1970-12-29 1972-07-27 Nisshin Flour Milling Co. Ltd., Tokio Verfahren zur Herstellung von Pyrimidinderivaten

Also Published As

Publication number Publication date
US3962435A (en) 1976-06-08
NL176563B (nl) 1984-12-03
SE7507943L (sv) 1975-07-10
CH569009A5 (cg-RX-API-DMAC7.html) 1975-11-14
GB1388180A (en) 1975-03-26
US3867527A (en) 1975-02-18
SE397349B (sv) 1977-10-31
AT321310B (de) 1975-03-25
SE7513517L (sv) 1975-12-01
JPS4862769A (cg-RX-API-DMAC7.html) 1973-09-01
AU467566B2 (en) 1975-12-04
NL176563C (nl) 1985-05-01
NL7215587A (cg-RX-API-DMAC7.html) 1973-06-05
CA994345A (en) 1976-08-03
JPS5523830B2 (cg-RX-API-DMAC7.html) 1980-06-25
US3850962A (en) 1974-11-26
AU4846272A (en) 1974-05-02
FR2162177B1 (cg-RX-API-DMAC7.html) 1975-08-08
DE2252807A1 (de) 1973-06-07
FR2162177A1 (cg-RX-API-DMAC7.html) 1973-07-13
BE792096A (fr) 1973-05-30

Similar Documents

Publication Publication Date Title
AU4498272A (en) Improved sliding clasp fastener construction
AU4549772A (en) Concealed sliding clasp fasteners
CA1003192A (en) Sliding clasp fastener
GB1184044A (en) Nitrofuryl-Oxadiazole Derivatives
ES399063A1 (es) Procedimiento para la obtencion de antibioticos con propie-dades antitumorales.
GB1390485A (en) Pyrazoles
AU460952B2 (en) Curtain heading tape
GB1365176A (en) Benzodiazepine derivatives
GB1413454A (en) 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof
GB1435685A (en) Hydroxyl-subst
GB1388180A (en) Acetals
GB1449404A (en) N-arylsulphonyl urea derivatives
SE7412147L (cg-RX-API-DMAC7.html)
IE34590B1 (en) Phenylethanolamine derivatives
ES410123A1 (es) Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato.
GB1388179A (en) Benzylpyrimidine derivatives
GB1406307A (en) Production of benzylpyrimidines
GB1451389A (en) Indolobenzazepines
AU455249B2 (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds
CA951726A (en) Sulfanilyl phenyl urea complex useful against marek's disease
AU462198B2 (en) 3'4'dideoxykanamycinb active against resistant bacteria and its synthesis
GB1224672A (en) Phenanthridine derivatives
AU437920B2 (en) Substituted 1,35-triazines and preparations containing them
GB1214663A (en) Benzodiazepine derivatives
GB1416281A (en) N-benzene-sulphonyl-erythromycylamine derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee